Table 2. Treatment received by patients with asymptomatic colorectal cancer in two trials.
|
Australasia
|
Canada
|
|||
|---|---|---|---|---|
| Immediate | Delayed | Immediate | Delayed | |
| Treatment details | n=50 | n=51 | n=34 | n=33 |
| Protocol chemotherapy (n, %) | 49 (98) | 33 (65) | 34 (100) | 26 (79) |
| Regimen | ||||
| Weekly FU–LV (n, %) | 22 (44) | 12 (24) | NA | NA |
| 4-weekly FU–LV (n, %) | 27 (54) | 21 (41) | 34 (100) | 26 (79) |
| Number of treatment cycles (median, interquartile range) | 6 (3–8) | 4.5 (1.5–7.5) | 6 (3–8) | 3 (2–6) |
| Delay to treatment start (median, range, in months)a | 0 (0–1) | 6 (1–34) | 0 (0) | 4 (1–28) |
NA=not available; FU–LV=5-fluorouracil and leucovorin.
a
Only patients who began treatment are included in this analysis.